These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2889256)

  • 21. Histamine-2 Receptor Antagonist Cannot Prevent Recurrent Peptic Ulcers in Patients With Atherosclerotic Diseases Who Receive Platelet ADP Receptor Antagonist Monotherapy: A Randomized-Controlled, Double-Blind, and Double-Dummy Trial.
    Hsu PI; Wu DC; Tsay FW; Cheng JS; Liu CP; Lai KH; Chen WC; Wang HM; Tsai TJ; Tsai KW; Kao SS
    Am J Gastroenterol; 2017 Feb; 112(2):282-289. PubMed ID: 27922030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The use of histamine H2 receptor blockaders in gastroenterology].
    Waldum HL; Petersen H
    Tidsskr Nor Laegeforen; 1983 Apr; 103(12):980-3. PubMed ID: 6136102
    [No Abstract]   [Full Text] [Related]  

  • 23. Famotidine versus pantoprazole for preventing bleeding in the upper gastrointestinal tract of critically ill patients receiving mechanical ventilation.
    Ojiako K; Shingala H; Schorr C; Gerber DR
    Am J Crit Care; 2008 Mar; 17(2):142-7. PubMed ID: 18310651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicenter, randomized, double-blind study comparing famotidine with ranitidine in the treatment of active duodenal ulcer disease.
    McCullough AJ
    Am J Med; 1986 Oct; 81(4B):17-24. PubMed ID: 2877570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized, double-blind comparison of famotidine with ranitidine in treatment of acute, benign gastric ulcer disease. Community-based study coupled with a patient registry.
    Brazer SR; Tyor MP; Pancotto FS; Brice RS; Garbutt JT; Wildermann NM; Harrell FE; Pryor DB; Liss CL; Root JK
    Dig Dis Sci; 1989 Jul; 34(7):1047-52. PubMed ID: 2568247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Famotidine (Pepcid).
    Med Lett Drugs Ther; 1987 Feb; 29(733):17-8. PubMed ID: 2880282
    [No Abstract]   [Full Text] [Related]  

  • 27. Famotidine (MK-208) in the treatment of gastric ulcer. Results of a multicenter double-blind controlled study.
    Paoluzi P; Torsoli A; Bianchi Porro G; Lazzaroni M; Barbara L; Corinaldesi R; Blasi A; Mangiameli A; Carratelli L; Cheli R
    Digestion; 1985; 32 Suppl 1():38-44. PubMed ID: 2866135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What are the differences between the H2-receptor antagonists?
    Schunack W
    Aliment Pharmacol Ther; 1987; 1 Suppl 1():493S-503S. PubMed ID: 2908767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacology of H2-receptor antagonists: an overview.
    Schunack W
    J Int Med Res; 1989; 17 Suppl 1():9A-16A. PubMed ID: 2566544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Famotidine. The ACG Committee on FDA-Related Matters with primary authorship by G. Friedman. American College of Gastroenterology.
    Am J Gastroenterol; 1987 Jun; 82(6):504-6. PubMed ID: 2883885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of acid inhibition on Campylobacter pylori.
    Blanco M; Pajares JM; Jimenez ML; Lopez-Brea M
    Scand J Gastroenterol Suppl; 1988; 142():107-9. PubMed ID: 2901784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
    De Natale G; De Natale F; Marino A
    Clin Ter; 1989 Apr; 129(1):3-16. PubMed ID: 2567647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of once-daily bedtime administration of famotidine and ranitidine in the short-term treatment of duodenal ulcer. A multicenter, double-blind, controlled study.
    Dobrilla G; De Pretis G; Piazzi L; Boero A; Camarri E; Crespi M; Fontana G; Ideo G; Manenti F; Marenco G
    Scand J Gastroenterol Suppl; 1987; 134():21-8. PubMed ID: 2889255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma sex steroid transport and histamine H2-receptor antagonists. Clinical implications.
    Berta L; Dusio P; Fortunati N; Fazzari A; Crua MR; Frairia R; Gaidano G
    Ann N Y Acad Sci; 1988; 538():304-12. PubMed ID: 2903712
    [No Abstract]   [Full Text] [Related]  

  • 35. Famotidine in the management of duodenal ulcer: experience in Italy.
    Barbara L; Corinaldesi R; Bianchi Porro G; Lazzaroni M; Blasi A; Mangiameli A; Carratelli L; Wilkins A; Cheli R; Bovero E
    Digestion; 1985; 32 Suppl 1():24-31. PubMed ID: 2866133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Experience in clinical use of quamatel in upper gastrointestinal hemorrhage].
    Shlevkov BA; Abramova LA; Toguzova DA
    Khirurgiia (Mosk); 2001; (7):45-8. PubMed ID: 11521310
    [No Abstract]   [Full Text] [Related]  

  • 37. [Famotidine versus placebo in prevention of the recurrence of duodenal ulcer disease. A multicenter study in Germany, Austria and Italy].
    Baglioni A; Barbara L; Bianchi-Porro G; Blasi A; Canelli B; Cheli R; Dal Monte R; Dammann HG; Francavilla A; Hentschel E
    Z Gastroenterol; 1985 Dec; 23(12):665-9. PubMed ID: 2868581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maintenance therapy of duodenal ulcer with famotidine. A multicenter United States study.
    Texter EC; Navab F; Mantell G; Berman R
    Am J Med; 1986 Oct; 81(4B):25-32. PubMed ID: 2877571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of famotidine on hepatic hemodynamics and peptic ulcer.
    Ohnishi K; Saito M; Nomura F; Okuda K; Suzuki N; Ohtsuki T; Goto N; Takashi M
    Am J Gastroenterol; 1987 May; 82(5):415-8. PubMed ID: 2883883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Famotidine versus ranitidine for the short-term treatment of duodenal ulcer.
    Simon B; Dammann HG; Jakob G; Miederer SE; Müller P; Ottenjann R; Paul F; Scholten T; Schütz E; Seifert E
    Digestion; 1985; 32 Suppl 1():32-7. PubMed ID: 2866134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.